Search - tctmd.com

Displaying 101 - 120 of 124

Sort: Relevancy | Date

Presentation TCT 2017

Take-home Messages for Managing Aortic Valve Disease From the 2017 AHA/ACC Focused Update

Presenter: Martin B. Leon, Patrick T. O'Gara, Allan Schwartz

October 30, 2017

Presentation TCT 2017

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: AHA

Presenter: Wayne B. Batchelor, George A. Mensah, Robert A. Harrington

October 30, 2017

News Conference News TCT 2016

Are Full, Formal Guidelines Still Useful in the Rapidly Changing TAVR Field?

Todd Neale

October 30, 2016

Presentation TCT 2016

Summary and Rationale For the ACC-AHA Guidelines on DAPT Duration After PCI

Presenter: John A. Bittl, Daniel I. Simon, Glenn N. Levine

October 30, 2016

Presentation TCT 2016

Future TAVR Guidelines: The Next ACC/AHA TAVR Focused Update and New Appropriate Use Criteria for TAVR

Presenter: Patrick T. O'Gara, Alec S. Vahanian, Samir R. Kapadia

October 30, 2016

Presentation TCT 2015

Intervention for Tricuspid Regurgitation: What Do the Guidelines Say? (ACC/AHA and ESC/EACTS)

Presenter: Rebecca T. Hahn, Joachim Schofer, Alec S. Vahanian

October 15, 2015

Presentation TCT 2015

What Defines Severe MR Post-AHA/ACC Guidelines?

Presenter: Jeroen J. Bax, Paul A. Grayburn

October 15, 2015

Presentation TCT 2014

Guideline Update: Aortic and Mitral Valve Disease and the 2014 AHA/ACC Guideline for Valvular Heart Disease

Presenter: Blase A. Carabello, George D. Dangas, Patrick T. O'Gara

September 15, 2014

News Conference News TCT 2014

PFO Closure for Stroke: A Call to Revise the Guidelines

September 14, 2014

Presentation TCT 2014

ASA/AHA Guidelines 2014: PFO Closure for Cryptogenic Stroke Is Now Class III LOE A! Is This the Final Word from the Neurology Community?

Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, David E. Thaler

September 13, 2014

Presentation TCT 2014

Important Changes in the New 2014 ACC/AHA Aortic Valve Guidelines: Aligning Definitions of Aortic Stenosis Severity with Treatment Recommendations

Presenter: A. Pieter Kappetein, Martin B. Leon, Howard C. Herrmann, Robert O. Bonow

September 13, 2014

News Conference News TCT 2013

High-Dose Statins before PCI Improved Outcomes in NSTE-ACS

November 06, 2013

Presentation TCT 2013

Introduction and AHA Policy Statement

Presenter: H. Robert Superko

October 31, 2013

News Conference News TCT 2013

In Memoriam: Andreas Gruentzig, MD, Receives TCT Career Achievement Award

October 29, 2013

Presentation TCT 2013

Distilling the Aortic Stenosis Guidelines (Synthesis of ESC and ACC/AHA): Essentials and Controversies

Presenter: Alec Vahanian

October 27, 2013

Presentation TCT 2013

Discontinuation of Long-Term Clopidogrel Therapy is Associated with Death and Myocardial Infarction after Saphenous Vein Graft Percutaneous Coronary Intervention

Presenter: Amit Sachdeva, Sumati Bavisetty, Gerald Beckham, Albert Shen, Vicken Aharonian, Prakash Mansukhani, Gregg Stone, Martin Leon, Jeffrey Moses, Naing Moore, Ric Hyett, Richard Contreras, Somjot Brar

January 31, 2013

Presentation TCT 2012

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

Presenter: Peter Brady

October 23, 2012

Presentation TCT 2012

The Association Between Duration of Clopidogrel Therapy After Saphenous Vein Graft Intervention And Long-Term Death And Myocardial Infarction

Presenter: Amit Sachdeva, Sumati Bavisetty, Gerald Beckham, Vicken Aharonian, Prakash Mansukhani, Gregg W. Stone, Naing Moore, Ric Hyett, Richard Contreras, Somjot S. Brar

January 03, 2012

Presentation TCT 2012

Long-term Mortality After Aortic Dissection in the Community - Results from the Kaiser Permanente Registry of Aortic Dissections (KP-RAD)

Presenter: Cuong Lam, Jackie Schwartz, Kevin Izquierdo, Aman Saw, Vicken Aharonian, Kevin Patel, Raymond Chen, George Vatakencherry, Michael Jorgensen, Kwok Yun, William Gray, Somjot S. Brar

January 03, 2012

Presentation TCT 2012

Determining a Troponin I Threshold for Predicting 30-Day Mortality: Results from the Troponin I In the Emergency Room (TiER) Study

Presenter: Saman Fakheri, Albert Shen, Steven Khan, Prakash Mansukhani, Vicken Aharonian, Richard Contreras, Michael Jorgensen, Somjot S. Brar

January 03, 2012

Advertisement

Take-home Messages for Managing Aortic Valve Disease From the 2017 AHA/ACC Focused Update

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: AHA

Are Full, Formal Guidelines Still Useful in the Rapidly Changing TAVR Field?

Summary and Rationale For the ACC-AHA Guidelines on DAPT Duration After PCI

Future TAVR Guidelines: The Next ACC/AHA TAVR Focused Update and New Appropriate Use Criteria for TAVR

Intervention for Tricuspid Regurgitation: What Do the Guidelines Say? (ACC/AHA and ESC/EACTS)

What Defines Severe MR Post-AHA/ACC Guidelines?

Guideline Update: Aortic and Mitral Valve Disease and the 2014 AHA/ACC Guideline for Valvular Heart Disease

PFO Closure for Stroke: A Call to Revise the Guidelines

ASA/AHA Guidelines 2014: PFO Closure for Cryptogenic Stroke Is Now Class III LOE A! Is This the Final Word from the Neurology Community?

Important Changes in the New 2014 ACC/AHA Aortic Valve Guidelines: Aligning Definitions of Aortic Stenosis Severity with Treatment Recommendations

High-Dose Statins before PCI Improved Outcomes in NSTE-ACS

Introduction and AHA Policy Statement

In Memoriam: Andreas Gruentzig, MD, Receives TCT Career Achievement Award

Distilling the Aortic Stenosis Guidelines (Synthesis of ESC and ACC/AHA): Essentials and Controversies

Discontinuation of Long-Term Clopidogrel Therapy is Associated with Death and Myocardial Infarction after Saphenous Vein Graft Percutaneous Coronary Intervention

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

The Association Between Duration of Clopidogrel Therapy After Saphenous Vein Graft Intervention And Long-Term Death And Myocardial Infarction

Long-term Mortality After Aortic Dissection in the Community - Results from the Kaiser Permanente Registry of Aortic Dissections (KP-RAD)

Determining a Troponin I Threshold for Predicting 30-Day Mortality: Results from the Troponin I In the Emergency Room (TiER) Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content